Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com

Myeloma Nurse Learning Programme Module 7 – Drug development and new treatments in myeloma Reflective Activity

Reflective Activity

How would you speak to patients if asked how new treatments are developed?
A patient hears that in America a licensed treatment is widely available but asks why it is not available in the UK. How would you respond?
Consider how you would discuss which new treatments are on the horizon for patients at different stages of disease.

Previous Section

Back to Module

Next Section